Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCA1 ABC1, HDLDT1, TGD ENSG00000165029 ATP-binding cassette, sub-family A (ABC1), member 1 9 104781002-104928237 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057283, CAB069889 Approved Approved Nucleoplasm
Vesicles Mixed adrenal gland: 38.1 ABCA10 EST698739 ENSG00000154263 ATP-binding cassette, sub-family A (ABC1), member 10 17 69147214-69244846 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014535 Uncertain Mixed ovary: 13.7 ABCA13 FLJ33876, FLJ33951 ENSG00000179869 ATP-binding cassette, sub-family A (ABC1), member 13 7 48171458-48647496 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA063601 Approved Vesicles
Centrosome
Cytosol Tissue enriched 10 bone marrow: 29.4 testis: 3.0 ABCA2 ABC2 ENSG00000107331 ATP-binding cassette, sub-family A (ABC1), member 2 9 137007227-137028922 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042886 Approved Tissue enriched 6 cerebral cortex: 98.2 thyroid gland: 17.0 ABCA3 ABC-C, ABC3, EST111653, LBM180 ENSG00000167972 ATP-binding cassette, sub-family A (ABC1), member 3 16 2275881-2340746 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007884 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 lung: 135.8 cerebral cortex: 51.7 ABCA5 EST90625 ENSG00000154265 ATP-binding cassette, sub-family A (ABC1), member 5 17 69244311-69327244 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA022032 Approved Expressed in all skin: 28.0 ABCA6 EST155051 ENSG00000154262 ATP-binding cassette, sub-family A (ABC1), member 6 17 69078702-69141888 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064878, HPA067180 Approved Nucleoplasm Tissue enhanced 0 liver: 41.4 ovary: 37.2 ABCA7 ABCX ENSG00000064687 ATP-binding cassette, sub-family A (ABC1), member 7 19 1040101-1065572 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041564 Supported Supported Golgi apparatus
Plasma membrane
Cell Junctions Mixed spleen: 25.8 ABCA8 KIAA0822 ENSG00000141338 ATP-binding cassette, sub-family A (ABC1), member 8 17 68867292-68955392 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044914 Approved Approved Nucleoplasm
Cytosol Mixed ovary: 67.2 ABCA9 EST640918 ENSG00000154258 ATP-binding cassette, sub-family A (ABC1), member 9 17 68974488-69061064 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054823 Uncertain Mixed ovary: 33.3 ABCB1 ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1 ENSG00000085563 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7 87503633-87713323 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001716, HPA002199 Approved Approved Nucleoplasm
Focal adhesion sites
Cytosol Tissue enhanced 0 adrenal gland: 138.6;small intestine: 83.9 kidney: 37.0 ABCB11 ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP ENSG00000073734 ATP-binding cassette, sub-family B (MDR/TAP), member 11 2 168922938-169031322 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019035 Supported Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 13 liver: 19.1 testis: 1.4 ABCB4 ABCB4, GBD1, MDR2, MDR3 , PFIC-3, PGY3 ENSG00000005471 ATP-binding cassette, sub-family B (MDR/TAP), member 4 7 87401697-87480435 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049395, HPA053288 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites Tissue enriched 6 liver: 69.2 adrenal gland: 10.7 ABCB5 ABCB5alpha, ABCB5beta, EST422562 ENSG00000004846 ATP-binding cassette, sub-family B (MDR/TAP), member 5 7 20615207-20777038 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026975 Uncertain Tissue enriched 7 epididymis: 31.7 gallbladder: 4.3 ABCB6 EST45597, MTABC3, umat ENSG00000115657 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group) 2 219209768-219218990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046723, HPA058011 Approved Validated Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol Expressed in all testis: 32.5 ABCC1 GS-X, MRP, MRP1 ENSG00000103222 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16 15949577-16143074 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002380 Uncertain Supported Plasma membrane Mixed parathyroid gland: 18.1 ABCC10 EST182763, MRP7, SIMRP7 ENSG00000124574 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 6 43427366-43450430 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041607, HPA045464 Approved Expressed in all smooth muscle: 12.4 ABCC11 MRP8 ENSG00000121270 ATP-binding cassette, sub-family C (CFTR/MRP), member 11 16 48166910-48247568 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031980, HPA031981, HPA031982, CAB032513 Uncertain Tissue enriched 11 breast: 63.2 prostate: 5.5 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ABCC3 cMOAT2, EST90757, MLP2, MOAT-D, MRP3 ENSG00000108846 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 17 50634777-50692252 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037136, HPA048483 Approved Approved Plasma membrane Mixed adrenal gland: 20.8 ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301446 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002476 Supported Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 prostate: 68.5 epididymis: 23.3 ABCC5 EST277145, MOAT-C, MRP5, SMRP ENSG00000114770 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 3 183919934-184018015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044067, HPA052295 Uncertain Supported Nucleus
Plasma membrane
Cell Junctions Expressed in all stomach: 72.0 ABCC6 ARA, EST349056, MLP1, MRP6, PXE, URG7 ENSG00000091262 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16 16148928-16223522 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038105 Supported Plasma membrane Tissue enhanced 0 kidney: 15.2;liver: 19.1 duodenum: 11.6 ABCC8 ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2 ENSG00000006071 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 11 17392885-17476845 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011451, HPA042318 Approved Approved Nucleoli
Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 11.7 adrenal gland: 7.6 ABCC9 CMD1O, SUR2 ENSG00000069431 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 12 21797401-21941402 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007279 Uncertain Approved Nucleoplasm
Cytosol Mixed smooth muscle: 34.9 ADCY1 AC1 ENSG00000164742 Adenylate cyclase 1 (brain) 7 45574140-45723116 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018364, HPA068274 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 35.1 cervix: 8.2 ADCY2 AC2, HBAC2, KIAA1060 ENSG00000078295 Adenylate cyclase 2 (brain) 5 7396208-7830081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB031482, HPA038015, HPA038483 Approved Tissue enhanced 0 cerebral cortex: 71.8;skeletal muscle: 35.8 prostate: 13.6 ADCY3 AC3 ENSG00000138031 Adenylate cyclase 3 2 24819169-24919839 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010223 Approved Expressed in all placenta: 121.3 ADCY4 AC4 ENSG00000129467 Adenylate cyclase 4 14 24318349-24335093 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB005070, HPA048344 Approved Tissue enhanced 0 placenta: 20.9 lung: 11.6 ADCY5 AC5 ENSG00000173175 Adenylate cyclase 5 3 123282296-123449758 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017730, HPA077682 Uncertain Uncertain Intermediate filaments Tissue enhanced 0 heart muscle: 72.9 seminal vesicle: 29.7 ADCY6 AC6 ENSG00000174233 Adenylate cyclase 6 12 48766194-48789037 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB018365 Approved Approved Golgi apparatus Mixed adipose tissue: 44.5 ADCY7 AC7, KIAA0037 ENSG00000121281 Adenylate cyclase 7 16 50246137-50318135 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041218, HPA048241 Uncertain Approved Cytosol Mixed spleen: 42.9 ADCY8 AC8, ADCY3, HBAC1 ENSG00000155897 Adenylate cyclase 8 (brain) 8 130780301-131042426 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018652, HPA024291 Supported Group enriched 8 cerebral cortex: 12.9;epididymis: 27.3;fallopian tube: 6.2 seminal vesicle: 1.9 ADCY9 AC9 ENSG00000162104 Adenylate cyclase 9 16 3953387-4116185 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041328, HPA044225 Approved Approved Cytosol Mixed thyroid gland: 31.8 ALG10 ALG10A, DIE2, FLJ14751 ENSG00000139133 ALG10, alpha-1,2-glucosyltransferase 12 34022281-34029694 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA043329, HPA063387 Approved Approved Endoplasmic reticulum Mixed parathyroid gland: 4.6 ALG10B KCR1 ENSG00000175548 ALG10B, alpha-1,2-glucosyltransferase 12 38316578-38329728 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043329, HPA063387 Approved Approved Endoplasmic reticulum Mixed parathyroid gland: 7.6 ALG12 ECM39 ENSG00000182858 ALG12, alpha-1,6-mannosyltransferase 22 49900229-49918458 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003076, HPA051665 Approved Approved Endoplasmic reticulum Expressed in all thyroid gland: 17.1 ALG6 ENSG00000088035 ALG6, alpha-1,3-glucosyltransferase 1 63367590-63438562 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062536 Supported Endoplasmic reticulum Mixed placenta: 11.8 ALG8 MGC2840 ENSG00000159063 ALG8, alpha-1,3-glucosyltransferase 11 78100936-78139660 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051898 Approved Approved Nucleoplasm Expressed in all testis: 85.6 ALG9 DIBD1 ENSG00000086848 ALG9, alpha-1,2-mannosyltransferase 11 111782195-111871581 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038575 Approved Approved Endoplasmic reticulum Expressed in all testis: 25.3 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Approved Approved Plasma membrane
Cytosol Expressed in all adipose tissue: 90.8 ATP10A ATP10C, ATPVA, ATPVC, KIAA0566 ENSG00000206190 ATPase, class V, type 10A 15 25677273-25865172 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041496, HPA042509 Uncertain Mixed lung: 10.5 ATP10B ATPVB, FLJ21477, KIAA0715 ENSG00000118322 ATPase, class V, type 10B 5 160563120-160852214 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034574 Uncertain Tissue enhanced 0 colon: 36.7;rectum: 40.8 gallbladder: 21.5 ATP10D ATPVD, KIAA1487 ENSG00000145246 ATPase, class V, type 10D 4 47485288-47593486 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA050808 Approved Supported Nucleoplasm
Plasma membrane Mixed parathyroid gland: 22.1 ATP11A ATPIH, ATPIS, KIAA1021 ENSG00000068650 ATPase, class VI, type 11A 13 112690329-112887168 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035583, HPA035584 Approved Validated Vesicles Expressed in all lung: 59.2 ATP11B ATPIF, ATPIR, KIAA0956 ENSG00000058063 ATPase, class VI, type 11B 3 182793500-182921635 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036237, HPA036238 Uncertain Approved Microtubule organizing center
Cytosol Expressed in all testis: 57.7 ATP11C ATPIG, ATPIQ ENSG00000101974 ATPase, class VI, type 11C X 139726346-139945276 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030830 Approved Mixed liver: 25.6 ATP12A ATP1AL1 ENSG00000075673 ATPase, H+/K+ transporting, nongastric, alpha polypeptide 13 24680411-24712493 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039526 Approved Tissue enhanced 0 esophagus: 12.8;placenta: 8.1;tonsil: 14.6 skin: 7.1 ATP13A1 ATP13A, CGI-152, FLJ31858, KIAA1825 ENSG00000105726 ATPase type 13A1 19 19645198-19663693 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031798, HPA049717 Approved Approved Vesicles Expressed in all parathyroid gland: 51.5 ATP13A2 CLN12, HSA9947, PARK9 ENSG00000159363 ATPase type 13A2 1 16985958-17011928 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037038, CAB037111, HPA050910, HPA054717 Approved Expressed in all cerebral cortex: 75.0 ATP13A3 AFURS1 ENSG00000133657 ATPase type 13A3 3 194402672-194498364 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029471 Approved Approved Nucleoli
Plasma membrane
Cytosol Expressed in all parathyroid gland: 146.4 ATP13A4 DKFZp761I1011, FLJ37958 ENSG00000127249 ATPase type 13A4 3 193402077-193593111 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051932 Approved Nucleoplasm Tissue enhanced 0 epididymis: 89.1;parathyroid gland: 129.5;thyroid gland: 68.2 lung: 56.5 ATP13A5 FLJ16025 ENSG00000187527 ATPase type 13A5 3 193274790-193378843 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA031771, HPA031774 Uncertain Tissue enhanced 0 breast: 17.8 salivary gland: 4.0 ATP1A1 ENSG00000163399 ATPase, Na+/K+ transporting, alpha 1 polypeptide 1 116372668-116410261 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018702, CAB069993 Supported Expressed in all parathyroid gland: 2441.5 ATP1A2 FHM2, MHP2 ENSG00000018625 ATPase, Na+/K+ transporting, alpha 2 polypeptide 1 160115759-160143591 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022230 Approved Group enriched 6 cerebral cortex: 435.6;skeletal muscle: 307.1 heart muscle: 59.1 ATP1A3 DYT12 ENSG00000105409 ATPase, Na+/K+ transporting, alpha 3 polypeptide 19 41966582-41997497 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033630, HPA045367, HPA056446 Supported Tissue enhanced 0 cerebral cortex: 376.4;heart muscle: 94.2 testis: 54.1 ATP2A1 ATP2A, SERCA1 ENSG00000196296 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 16 28878405-28904509 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002310, CAB032706 Supported Approved Endoplasmic reticulum Tissue enriched 95 skeletal muscle: 2782.7 esophagus: 29.2 ATP2A2 ATP2B, DAR, SERCA2 ENSG00000174437 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 12 110280756-110351093 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062605, HPA067892 Supported Supported Nucleoplasm Expressed in all skeletal muscle: 1006.6 ATP2A3 SERCA3 ENSG00000074370 ATPase, Ca++ transporting, ubiquitous 17 3923870-3964464 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007180, CAB010882 Approved Expressed in all lymph node: 119.9 ATP2B1 PMCA1 ENSG00000070961 ATPase, Ca++ transporting, plasma membrane 1 12 89588049-89709300 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005605, HPA011166, HPA012945 Supported Supported Plasma membrane Expressed in all cerebral cortex: 144.0 ATP2B2 PMCA2 ENSG00000157087 ATPase, Ca++ transporting, plasma membrane 2 3 10324023-10708031 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005606 Supported Tissue enriched 7 cerebral cortex: 63.0 salivary gland: 9.2 ATP2B3 CFAP39, CLA2, PMCA3, SCAX1 ENSG00000067842 ATPase, Ca++ transporting, plasma membrane 3 X 153517676-153582939 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001583 Supported Uncertain Golgi apparatus
Plasma membrane Group enriched 8 adrenal gland: 12.2;cerebral cortex: 19.1 fallopian tube: 2.0 ATP2B4 ATP2B2, MXRA1, PMCA4 ENSG00000058668 ATPase, Ca++ transporting, plasma membrane 4 1 203626561-203744081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016118, HPA040431 Supported Supported Plasma membrane Expressed in all smooth muscle: 251.3 ATP2C1 ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1 ENSG00000017260 ATPase, Ca++ transporting, type 2C, member 1 3 130850595-131016712 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010207, HPA035116, HPA069684 Supported Validated Golgi apparatus Expressed in all prostate: 136.8 ATP2C2 KIAA0703, SPCA2 ENSG00000064270 ATPase, Ca++ transporting, type 2C, member 2 16 84368527-84464187 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052262, HPA075812 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 rectum: 39.0 skin: 30.1 ATP4A ATP6A ENSG00000105675 ATPase, H+/K+ exchanging, alpha polypeptide 19 35550043-35563658 Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039154 Supported Tissue enriched 250 stomach: 537.7 pancreas: 2.1 ATP8A1 ATPIA ENSG00000124406 ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 4 42408373-42657105 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049948, HPA052935 Approved Supported Vesicles Tissue enhanced 0 parathyroid gland: 67.5;thyroid gland: 66.3 cerebral cortex: 58.4 ATP8A2 ATPIB, ML-1 ENSG00000132932 ATPase, aminophospholipid transporter, class I, type 8A, member 2 13 25372071-26025851 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039926, HPA040033 Approved Supported Nucleoplasm
Plasma membrane Group enriched 6 cerebral cortex: 26.5;testis: 10.6 adrenal gland: 2.9 ATP8B1 ATPIC, BRIC, FIC1, PFIC, PFIC1 ENSG00000081923 ATPase, aminophospholipid transporter, class I, type 8B, member 1 18 57646426-57803101 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018673, HPA018674 Supported Expressed in all colon: 96.9 ATP8B2 ATPID, KIAA1137 ENSG00000143515 ATPase, aminophospholipid transporter, class I, type 8B, member 2 1 154325553-154351307 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046680 Approved Approved Golgi apparatus
Vesicles
Cytosol Mixed smooth muscle: 60.2 ATP8B4 ATPIM, KIAA1939 ENSG00000104043 ATPase, class I, type 8B, member 4 15 49858238-50182817 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040254 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 bone marrow: 23.1 endometrium: 9.2 ATP9A ATPIIA, KIAA0611 ENSG00000054793 ATPase, class II, type 9A 20 51596514-51768634 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020699, HPA035630 Approved Expressed in all cerebral cortex: 156.2 ATP9B ATPIIB ENSG00000166377 ATPase, class II, type 9B 18 79069285-79378283 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029364 Approved Expressed in all testis: 39.0 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supported Approved Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 18.1 stomach: 6.4 CACNA1B CACNL1A5, CACNN, Cav2.2 ENSG00000148408 Calcium channel, voltage-dependent, N type, alpha 1B subunit 9 137877789-138124624 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044347 Uncertain Group enriched 8 adrenal gland: 3.7;cerebral cortex: 14.9;fallopian tube: 4.8;testis: 7.6 prostate: 1.0 CACNA1C CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS ENSG00000151067 Calcium channel, voltage-dependent, L type, alpha 1C subunit 12 1970786-2697950 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039796 Supported Tissue enhanced 0 smooth muscle: 30.9 endometrium: 26.2 CACNA1D CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2 ENSG00000157388 Calcium channel, voltage-dependent, L type, alpha 1D subunit 3 53494656-53813733 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA020215 Uncertain Approved Nuclear membrane Mixed fallopian tube: 13.7 CACNA1E BII, CACH6, CACNL1A6, Cav2.3 ENSG00000198216 Calcium channel, voltage-dependent, R type, alpha 1E subunit 1 181413102-181808084 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042515 Approved Plasma membrane
Actin filaments
Cytosol Tissue enriched 7 cerebral cortex: 10.3 adrenal gland: 1.3 CACNA1G Cav3.1, NBR13 ENSG00000006283 Calcium channel, voltage-dependent, T type, alpha 1G subunit 17 50561068-50627474 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA004714 Uncertain Tissue enhanced 0 cerebral cortex: 10.6;cervix, uterine: 8.5 endometrium: 5.2 CACNA1H Cav3.2 ENSG00000196557 Calcium channel, voltage-dependent, T type, alpha 1H subunit 16 1153241-1221771 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA039125 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 ovary: 50.6 seminal vesicle: 46.9 CACNA1S CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5 ENSG00000081248 Calcium channel, voltage-dependent, L type, alpha 1S subunit 1 201039512-201112566 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009507, HPA048892, HPA056815 Supported Tissue enriched 34 skeletal muscle: 103.0 esophagus: 3.0 CASD1 C7orf12, FLJ21213, FLJ21879 ENSG00000127995 CAS1 domain containing 1 7 94509219-94557019 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA044404 Uncertain Approved Nucleoplasm Expressed in all cerebral cortex: 38.9 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supported Tissue enhanced 0 gallbladder: 89.6;rectum: 50.1 colon: 47.0 CHPT1 CPT1 ENSG00000111666 Choline phosphotransferase 1 12 101696947-101744140 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067643 Approved Approved Vesicles Expressed in all breast: 124.5 CLCN2 ClC-2, CLC2, EJM6 ENSG00000114859 Chloride channel, voltage-sensitive 2 3 184346185-184361651 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009397, HPA014545, HPA024108 Approved Approved Cytosol Mixed testis: 22.0 CLCN3 ClC-3, CLC3 ENSG00000109572 Chloride channel, voltage-sensitive 3 4 169612633-169723673 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044723 Approved Approved Cytosol Expressed in all cerebral cortex: 104.4 CLCN4 ClC-4, CLC4 ENSG00000073464 Chloride channel, voltage-sensitive 4 X 10156945-10237660 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031313, HPA063637 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 49.2;epididymis: 27.6 skeletal muscle: 14.6 CLCN5 ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN ENSG00000171365 Chloride channel, voltage-sensitive 5 X 49922615-50099235 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000401, HPA003213 Uncertain Supported Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 epididymis: 33.2;kidney: 51.6 placenta: 9.5 CLCN6 CLC-6, KIAA0046 ENSG00000011021 Chloride channel, voltage-sensitive 6 1 11806096-11843144 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA032097 Approved Approved Plasma membrane
Cytosol Mixed cerebral cortex: 31.2 CLCN7 CLC-7, CLC7, OPTA2, PPP1R63 ENSG00000103249 Chloride channel, voltage-sensitive 7 16 1444934-1475580 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043019, HPA043586 Supported Supported Nucleoplasm Expressed in all parathyroid gland: 40.4 CLCNKA hClC-Ka ENSG00000186510 Chloride channel, voltage-sensitive Ka 1 16018875-16034050 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA057717 Approved Group enriched 9 kidney: 63.9;parathyroid gland: 39.6 thyroid gland: 5.5 CLCNKB hClC-Kb ENSG00000184908 Chloride channel, voltage-sensitive Kb 1 16043736-16057308 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057717 Approved Tissue enhanced 0 kidney: 107.5 salivary gland: 22.1 CWH43 CWH43-C, FLJ21511 ENSG00000109182 Cell wall biogenesis 43 C-terminal homolog 4 48986247-49062081 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042814, HPA048140 Uncertain Tissue enhanced 0 prostate: 69.1 skin: 29.7 DHCR7 SLOS ENSG00000172893 7-dehydrocholesterol reductase 11 71428193-71452868 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044280 Approved Supported Endoplasmic reticulum
Cytosol Expressed in all adrenal gland: 116.0 DIRC2 FLJ14784, RCC4 ENSG00000138463 Disrupted in renal carcinoma 2 3 122794795-122881139 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072579 Supported Vesicles Expressed in all parathyroid gland: 15.9 DISP1 DISPA, DKFZP434I0428, MGC13130, MGC16796 ENSG00000154309 Dispatched homolog 1 (Drosophila) 1 222872271-223005995 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051411 Uncertain Approved Nuclear bodies Mixed lung: 15.8 DISP2 DISPB, HsT16908, KIAA1742 ENSG00000140323 Dispatched homolog 2 (Drosophila) 15 40358235-40378639 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059903 Uncertain Approved Nucleoplasm
Vesicles Tissue enhanced 0 cerebral cortex: 7.5 thyroid gland: 1.9 DOLK DK1, KIAA1094, TMEM15 ENSG00000175283 Dolichol kinase 9 128945530-128947619 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054813 Uncertain Nucleus
Cytosol Mixed parathyroid gland: 24.3 DPAGT1 ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT ENSG00000172269 Dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) 11 119096503-119108331 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053878 Approved Mixed parathyroid gland: 30.3 DPY19L1 KIAA0877 ENSG00000173852 Dpy-19-like 1 (C. elegans) 7 34928876-35038271 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059139 Uncertain Approved Vesicles Expressed in all testis: 69.2 DPY19L2 FLJ32949, SPATA34 ENSG00000177990 Dpy-19-like 2 (C. elegans) 12 63558913-63668939 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071264 Approved Nucleus
Mitochondria Tissue enriched 8 testis: 111.5 parathyroid gland: 14.6 DPY19L3 ENSG00000178904 Dpy-19-like 3 (C. elegans) 19 32405543-32485895 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008325 Approved Approved Microtubules Mixed cerebral cortex: 20.4 DPY19L4 ENSG00000156162 Dpy-19-like 4 (C. elegans) 8 94719703-94793836 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024780 Approved Approved Vesicles Expressed in all parathyroid gland: 36.2 FLVCR1 AXPC1, FLVCR, MFSD7B, PCA ENSG00000162769 Feline leukemia virus subgroup C cellular receptor 1 1 212858255-212899363 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046646 Approved Approved Cell Junctions Tissue enhanced 0 small intestine: 21.9 duodenum: 10.0 FLVCR2 C14orf58, FLJ20371, MFSD7C ENSG00000119686 Feline leukemia virus subgroup C cellular receptor family, member 2 14 75578617-75663214 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037984 Supported Tissue enhanced 0 testis: 38.5 small intestine: 27.4 GPR155 DEP.7, DEPDC3, FLJ31819, PGR22 ENSG00000163328 G protein-coupled receptor 155 2 174431571-174487094 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036159, HPA057384 Approved Approved Nuclear bodies
Cytosol Expressed in all stomach: 44.0 HGSNAT FLJ32731, HGNAT, TMEM76 ENSG00000165102 Heparan-alpha-glucosaminide N-acetyltransferase 8 43140455-43202855 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029578 Approved Expressed in all parathyroid gland: 50.4 HHAT FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn ENSG00000054392 Hedgehog acyltransferase 1 210328252-210676296 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016462 Approved Approved Golgi apparatus Mixed thyroid gland: 7.8 HHATL C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3 ENSG00000010282 Hedgehog acyltransferase-like 3 42692663-42702827 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA018174 Supported Tissue enhanced 0 heart muscle: 333.2;skeletal muscle: 97.6 cerebral cortex: 53.4 HIAT1 DKFZP564L0864 ENSG00000156875 Hippocampus abundant transcript 1 1 100038097-100083377 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA073681 Approved Vesicles Expressed in all parathyroid gland: 197.2 HIATL1 FLJ14753 ENSG00000148110 Hippocampus abundant transcript-like 1 9 94374551-94461042 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA017978 Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 251.1 KIAA1919 MFSD4B, MGC33953 ENSG00000173214 KIAA1919 6 111259348-111271167 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA031784 Approved Uncertain Intermediate filaments Mixed placenta: 5.0 LMF2 TMEM112B, TMEM153 ENSG00000100258 Lipase maturation factor 2 22 50502949-50507691 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062626 Approved Approved Centrosome Expressed in all pancreas: 38.0 MARCH6 MARCH-VI, RNF176, TEB4 ENSG00000145495 Membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase 5 10353703-10440388 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040841, HPA063246 Approved Supported Endoplasmic reticulum Expressed in all parathyroid gland: 95.0 MFSD1 FLJ14153, UG0581B09 ENSG00000118855 Major facilitator superfamily domain containing 1 3 158732198-158829719 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA057924, HPA065858 Approved Approved Nucleus
Nucleoli Expressed in all spleen: 35.8 MFSD10 IT10C3, TETRAN ENSG00000109736 Major facilitator superfamily domain containing 10 4 2930561-2934859 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043209 Uncertain Approved Nucleoplasm
Nuclear membrane Expressed in all bone marrow: 41.3 MFSD11 FLJ20226, FLJ22196 ENSG00000092931 Major facilitator superfamily domain containing 11 17 76735865-76781449 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA022001 Uncertain Approved Nuclear speckles Expressed in all parathyroid gland: 33.9 MFSD12 C19orf28, MGC20700, PP3501 ENSG00000161091 Major facilitator superfamily domain containing 12 19 3538261-3574290 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042149, HPA043088 Uncertain Approved Nucleoplasm
Mitochondria Expressed in all skin: 64.2 MFSD2A FLJ14490, MFSD2 ENSG00000168389 Major facilitator superfamily domain containing 2A 1 39955112-39969968 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043107 Uncertain Approved Plasma membrane
Cytosol
Cytoplasmic bodies Tissue enhanced 0 epididymis: 114.6;seminal vesicle: 109.6 testis: 63.3 MFSD2B ENSG00000205639 Major facilitator superfamily domain containing 2B 2 24010081-24063321 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA044145 Supported Tissue enriched 9 bone marrow: 7.2 placenta: 0.7 MFSD3 ENSG00000167700 Major facilitator superfamily domain containing 3 8 144509074-144511213 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056013 Uncertain Approved Vesicles Expressed in all parathyroid gland: 14.2 MFSD5 MGC11308 ENSG00000182544 Major facilitator superfamily domain containing 5 12 53251251-53254405 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039773 Uncertain Expressed in all skin: 49.7 MFSD6 FLJ20160 ENSG00000151690 Major facilitator superfamily domain containing 6 2 190408355-190509205 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022274 Approved Approved Nucleoplasm
Actin filaments
Cytosol Expressed in all cerebral cortex: 79.2 MFSD6L FLJ35773 ENSG00000185156 Major facilitator superfamily domain containing 6-like 17 8797162-8799349 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023164 Uncertain Tissue enhanced 0 testis: 29.7 parathyroid gland: 8.3 MFSD7 FLJ22269, LP2561 ENSG00000169026 Major facilitator superfamily domain containing 7 4 681829-689441 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043593 Uncertain Mixed parathyroid gland: 14.3 MFSD8 CLN7, MGC33302 ENSG00000164073 Major facilitator superfamily domain containing 8 4 127917805-127965995 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044802 Approved Supported Nucleoplasm
Vesicles Expressed in all parathyroid gland: 12.2 MT-CO1 COI, COX1, MTCO1 ENSG00000198804 Mitochondrially encoded cytochrome c oxidase I MT 5904-7445 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016241, HPA069328 Supported Supported Mitochondria Expressed in all heart muscle: 79793.3 MT-ND4 LHON, MTND4, NAD4, ND4 ENSG00000198886 Mitochondrially encoded NADH dehydrogenase 4 MT 10760-12137 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053928 Approved Expressed in all heart muscle: 38133.1 NALCN bA430M15.1, CanIon, VGCNL1 ENSG00000102452 Sodium leak channel, non selective 13 101053776-101416492 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031889, HPA031890, HPA031958 Approved Tissue enhanced 0 cerebral cortex: 28.2 adrenal gland: 6.0 NNT ENSG00000112992 Nicotinamide nucleotide transhydrogenase 5 43602692-43707405 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004829, CAB004975 Supported Validated Mitochondria Expressed in all heart muscle: 139.6 NPC1 ENSG00000141458 Niemann-Pick disease, type C1 18 23506184-23586898 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026618, CAB070132 Approved Expressed in all parathyroid gland: 110.9 NPC1L1 ENSG00000015520 NPC1-like 1 7 44512535-44541315 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB070127, CAB070128 Supported Tissue enhanced 0 duodenum: 58.7;small intestine: 59.3 liver: 14.2 OTOP1 ENSG00000163982 Otopetrin 1 4 4188803-4226889 Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA035599 Uncertain Not detected skin: 0.2 OTOP2 ENSG00000183034 Otopetrin 2 17 74924275-74933912 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA024524, HPA053090 Uncertain Tissue enhanced 0 colon: 20.3;rectum: 11.6 testis: 3.9 OTOP3 ENSG00000182938 Otopetrin 3 17 74935719-74949992 Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level HPA023498 Uncertain Not detected small intestine: 0.5 PCNX KIAA0805, KIAA0995, PCNXL1, pecanex ENSG00000100731 Pecanex homolog (Drosophila) 14 70907405-71115382 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053532 Approved Nucleoplasm Expressed in all testis: 38.1 PCNXL2 FLJ11383, KIAA0435 ENSG00000135749 Pecanex-like 2 (Drosophila) 1 232983435-233295713 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013815, HPA014427 Uncertain Approved Endoplasmic reticulum Mixed cerebral cortex: 14.0 PCNXL3 FLJ22427 ENSG00000197136 Pecanex-like 3 (Drosophila) 11 65615773-65637439 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018084 Uncertain Approved Cytosol Mixed testis: 17.3 PCNXL4 C14orf135 ENSG00000126773 Pecanex-like 4 (Drosophila) 14 60091911-60169133 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA002076, HPA003390 Uncertain Approved Cytosol Expressed in all parathyroid gland: 31.6 PIEZO1 FAM38A, KIAA0233 ENSG00000103335 Piezo-type mechanosensitive ion channel component 1 16 88715343-88785211 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047185 Uncertain Mixed adipose tissue: 42.0 PIEZO2 C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771 ENSG00000154864 Piezo-type mechanosensitive ion channel component 2 18 10666483-11148762 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015986, HPA031974, HPA031975, HPA040616 Approved Approved Vesicles Mixed lung: 12.8 PIGB ENSG00000069943 Phosphatidylinositol glycan anchor biosynthesis, class B 15 55318960-55355648 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039929 Uncertain Uncertain Plasma membrane
Cytosol Mixed parathyroid gland: 22.8 PIGG FLJ20265, GPI7, LAS21 ENSG00000174227 Phosphatidylinositol glycan anchor biosynthesis, class G 4 499210-540196 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015997 Uncertain Uncertain Nucleoplasm
Vesicles Expressed in all parathyroid gland: 34.9 PIGM GPI-MT-I ENSG00000143315 Phosphatidylinositol glycan anchor biosynthesis, class M 1 160027673-160031991 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047418 Uncertain Mixed parathyroid gland: 16.1 PIGN MDC4, PIG-N ENSG00000197563 Phosphatidylinositol glycan anchor biosynthesis, class N 18 62043567-62187118 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039922, HPA040374 Approved Supported Plasma membrane
Cytosol Expressed in all parathyroid gland: 31.3 PIGO DKFZp434M222, FLJ00135 ENSG00000165282 Phosphatidylinositol glycan anchor biosynthesis, class O 9 35088688-35096601 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014905 Approved Nucleus
Nucleoli Expressed in all parathyroid gland: 73.2 PIGU bA346K17.2, CDC91L1, GAB1 ENSG00000101464 Phosphatidylinositol glycan anchor biosynthesis, class U 20 34560542-34698790 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041706, HPA046766 Uncertain Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 47.2 PIGW FLJ37433, Gwt1 ENSG00000277161 Phosphatidylinositol glycan anchor biosynthesis, class W 17 36535020-36539310 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA023499 Approved Plasma membrane Mixed appendix: 5.3 PIGZ FLJ12768, MGC52163, SMP3 ENSG00000119227 Phosphatidylinositol glycan anchor biosynthesis, class Z 3 196946343-196969060 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA058599, HPA059920 Approved Uncertain Vesicles Tissue enhanced 0 colon: 18.8;rectum: 18.4 cerebral cortex: 10.9 PKD1 PBP, Pc-1, TRPP1 ENSG00000008710 Polycystic kidney disease 1 (autosomal dominant) 16 2088710-2135898 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB046448 Approved Mixed cerebral cortex: 21.6 PKD1L1 PRO19563 ENSG00000158683 Polycystic kidney disease 1 like 1 7 47774652-47948491 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020422, HPA022424 Uncertain Tissue enhanced 0 testis: 2.4 adipose tissue: 1.8 PKDREJ ENSG00000130943 Polycystin (PKD) family receptor for egg jelly 22 46255663-46263355 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034587 Supported Tissue enriched 9 testis: 6.2 skin: 0.7 POMT1 LGMD2K ENSG00000130714 Protein-O-mannosyltransferase 1 9 131502902-131523806 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065252 Approved Golgi apparatus Expressed in all testis: 62.7 POMT2 LGMD2N ENSG00000009830 Protein-O-mannosyltransferase 2 14 77274956-77320884 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003663 Uncertain Expressed in all testis: 28.8 PTCH1 BCNS, NBCCS, PTCH ENSG00000185920 Patched 1 9 95442980-95517057 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB013717, HPA075072 Uncertain Approved Golgi apparatus Tissue enhanced 0 cervix, uterine: 41.6 endometrium: 27.2 PTCHD1 FLJ30296 ENSG00000165186 Patched domain containing 1 X 23334015-23404372 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046110 Uncertain Tissue enhanced 0 epididymis: 9.6 seminal vesicle: 5.3 PTCHD2 DISP3, KIAA1337 ENSG00000204624 Patched domain containing 2 1 11479166-11537584 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA054579 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched 14 cerebral cortex: 8.7;testis: 4.3 adrenal gland: 0.4 PTCHD4 C6orf138, dJ402H5.2, FLJ41841 ENSG00000244694 Patched domain containing 4 6 47878028-48068689 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041276 Uncertain Approved Plasma membrane
Cytosol Mixed seminal vesicle: 2.8 RFT1 CDG1N ENSG00000163933 RFT1 homolog 3 53088483-53130462 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060327 Approved Vesicles Expressed in all testis: 25.8 RHAG CD241, RH50A, SLC42A1 ENSG00000112077 Rh-associated glycoprotein 6 49605158-49636839 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055331 Approved Tissue enriched 24 bone marrow: 73.8 placenta: 3.0 RHBG SLC42A2 ENSG00000132677 Rh family, B glycoprotein (gene/pseudogene) 1 156369212-156385219 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA042726, HPA048489 Approved Approved Nucleoplasm Tissue enhanced 0 kidney: 3.5;ovary: 2.0 liver: 0.6 RHCG C15orf6, PDRC2, RHGK, SLC42A3 ENSG00000140519 Rh family, C glycoprotein 15 89471398-89496613 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041874, HPA043317 Supported Tissue enriched 7 esophagus: 2912.7 tonsil: 436.1 RNF139 HRCA1, RCA1, TRC8 ENSG00000170881 Ring finger protein 139 8 124474738-124487914 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001202 Approved Expressed in all testis: 114.1 RNF145 FLJ31951 ENSG00000145860 Ring finger protein 145 5 159157409-159210053 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036562 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all lung: 109.1 RP11-108O10.8 ENSG00000258529 11 111786286-111879425 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA038575 Uncertain Approved Endoplasmic reticulum Tissue enhanced 0 testis: 1.7 skin: 0.9 RP11-545J16.1 ENSG00000257046 12 20815674-21090245 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA050892 Uncertain Tissue enriched 13 breast: 26.4 liver: 2.0 SCN11A NaN, Nav1.9, SCN12A, SNS-2 ENSG00000168356 Sodium channel, voltage gated, type XI alpha subunit 3 38845769-38950561 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA036746, HPA036747 Uncertain Tissue enhanced 0 placenta: 3.7;spleen: 5.4 testis: 2.1 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage gated, type I alpha subunit 2 165989160-166128047 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA078664 Approved Nucleoplasm
Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 12.0;fallopian tube: 4.4;lung: 3.2 testis: 2.2 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage gated, type II alpha subunit 2 165239402-165392310 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supported Tissue enriched 22 cerebral cortex: 58.5 kidney: 2.7 SCN3A Nav1.3 ENSG00000153253 Sodium channel, voltage gated, type III alpha subunit 2 165087522-165204067 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035396 Approved Tissue enriched 6 cerebral cortex: 18.0 adrenal gland: 3.0 SCN4A HYKPP, HYPP, Nav1.4, SkM1 ENSG00000007314 Sodium channel, voltage gated, type IV alpha subunit 17 63938554-63972918 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053992 Approved Nucleoplasm
Microtubule organizing center Group enriched 9 adipose tissue: 12.3;skeletal muscle: 47.2 thyroid gland: 3.3 SCN7A NaG, Nav2.1, Nav2.2, SCN6A ENSG00000136546 Sodium channel, voltage gated, type VII alpha subunit 2 166403573-166494247 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004879 Uncertain Tissue enhanced 0 ovary: 63.0 lung: 41.0 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022169 Supported Vesicles
Cell Junctions Tissue enriched 6 cerebral cortex: 22.1 testis: 3.5 SCN9A ETHA, Nav1.7, NE-NA, NENA, PN1 ENSG00000169432 Sodium channel, voltage gated, type IX alpha subunit 2 166195185-166375993 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013679, HPA061843 Uncertain Approved Plasma membrane
Actin filaments
Focal adhesion sites Tissue enhanced 0 testis: 9.1 placenta: 5.9 SERINC1 KIAA1253, TDE1L, TDE2, TMS-2 ENSG00000111897 Serine incorporator 1 6 122443354-122471822 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035738, HPA035739 Uncertain Approved Cytosol Expressed in all cerebral cortex: 617.2 SERINC2 FKSG84, PRO0899, TDE2, TDE2L ENSG00000168528 Serine incorporator 2 1 31409565-31434680 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA005974 Approved Mixed urinary bladder: 138.8 SERINC3 AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 ENSG00000132824 Serine incorporator 3 20 44496221-44522109 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA048116 Uncertain Expressed in all testis: 200.8 SERINC4 FLJ40363 ENSG00000184716 Serine incorporator 4 15 43794162-43800221 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018526 Uncertain Tissue enriched 10 testis: 2.2 endometrium: 0.2 SERINC5 C5orf12, TPO1 ENSG00000164300 Serine incorporator 5 5 80111651-80256079 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037898, HPA037899 Supported Uncertain Nucleus
Golgi apparatus
Vesicles Mixed testis: 55.9 SIDT1 FLJ20174, SID-1 ENSG00000072858 SID1 transmembrane family, member 1 3 113532296-113629578 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035862 Approved Mixed rectum: 10.7 SIDT2 CGI-40 ENSG00000149577 SID1 transmembrane family, member 2 11 117178733-117197445 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052352 Approved Expressed in all prostate: 59.7 SLC10A5 ENSG00000253598 Solute carrier family 10, member 5 8 81693607-81696174 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA025966 Uncertain Approved Plasma membrane Mixed liver: 3.0 SLC11A1 LSH, NRAMP, NRAMP1 ENSG00000018280 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 2 218382029-218396894 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029590 Uncertain Tissue enhanced 0 appendix: 9.3;lung: 13.2 spleen: 4.8 SLC11A2 DCT1, DMT1, NRAMP2 ENSG00000110911 Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 12 50979401-51028566 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032139, HPA032140 Uncertain Supported Mitochondria Expressed in all thyroid gland: 74.8 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC12A2 BSC, BSC2, NKCC1, PPP1R141 ENSG00000064651 Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 5 128083766-128189688 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020130, HPA063697 Approved Approved Vesicles
Plasma membrane Expressed in all rectum: 66.4 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supported Tissue enriched 107 kidney: 109.3 lymph node: 1.0 SLC12A4 KCC1 ENSG00000124067 Solute carrier family 12 (potassium/chloride transporter), member 4 16 67943474-67969601 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041138 Approved Approved Endosomes Expressed in all parathyroid gland: 62.5 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supported Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC12A6 ACCPN, KCC3 ENSG00000140199 Solute carrier family 12 (potassium/chloride transporter), member 6 15 34229996-34338060 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034563 Uncertain Approved Vesicles
Cytosol Mixed testis: 46.2 SLC12A7 DKFZP434F076, KCC4 ENSG00000113504 Solute carrier family 12 (potassium/chloride transporter), member 7 5 1050376-1112035 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041652 Approved Uncertain Cytosol Mixed duodenum: 25.0 SLC12A8 CCC9 ENSG00000221955 Solute carrier family 12, member 8 3 125082636-125212864 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031123 Uncertain Supported Nucleoplasm Tissue enhanced 0 thyroid gland: 39.4 gallbladder: 16.3 SLC13A1 NAS1, NaSi-1 ENSG00000081800 Solute carrier family 13 (sodium/sulfate symporter), member 1 7 123113531-123199986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA053615, HPA062714 Approved Tissue enriched 6 kidney: 84.4 small intestine: 14.3 SLC13A2 NaDC-1 ENSG00000007216 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 17 28473293-28497781 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014963 Supported Tissue enhanced 0 duodenum: 70.6;small intestine: 55.4 kidney: 19.6 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supported Tissue enriched 7 kidney: 428.6 placenta: 60.6 SLC13A4 SUT-1, SUT1 ENSG00000164707 Solute carrier family 13 (sodium/sulfate symporter), member 4 7 135681237-135729258 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048582 Approved Tissue enriched 10 placenta: 76.2 testis: 7.3 SLC13A5 NACT ENSG00000141485 Solute carrier family 13 (sodium-dependent citrate transporter), member 5 17 6684713-6713567 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044343, HPA057088 Approved Uncertain Nucleoplasm Tissue enriched 9 liver: 118.1 salivary gland: 12.8 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SLC15A3 hPTR3, PHT2 ENSG00000110446 Solute carrier family 15 (oligopeptide transporter), member 3 11 60937083-60952530 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047880, HPA057642 Approved Supported Vesicles Expressed in all lung: 102.3 SLC15A4 PHT1, PTR4 ENSG00000139370 Solute carrier family 15 (oligopeptide transporter), member 4 12 128793191-128823983 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA016713 Approved Expressed in all lymph node: 27.7 SLC15A5 ENSG00000188991 Solute carrier family 15, member 5 12 16188485-16277685 Predicted membrane proteins, Transporters No evidence No evidence No evidence HPA041638 Uncertain Not detected testis: 0.3 SLC16A1 MCT, MCT1 ENSG00000155380 Solute carrier family 16 (monocarboxylate transporter), member 1 1 112911847-112957013 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003324, CAB017489, HPA071055 Supported Validated Plasma membrane
Cell Junctions Mixed testis: 32.0 SLC16A10 MCT10, TAT1 ENSG00000112394 Solute carrier family 16 (aromatic amino acid transporter), member 10 6 111087503-111231194 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016860 Approved Approved Vesicles
Cell Junctions Tissue enhanced 0 placenta: 38.2 skin: 22.5 SLC16A13 MCT13 ENSG00000174327 Solute carrier family 16, member 13 17 7036075-7040121 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA065245 Supported Golgi apparatus Mixed liver: 15.4 SLC16A14 FLJ30794, MCT14 ENSG00000163053 Solute carrier family 16, member 14 2 230034974-230068999 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA040518 Uncertain Approved Cytosol Mixed parathyroid gland: 14.6 SLC16A2 AHDS, DXS128, MCT7, MCT8, MRX22, XPCT ENSG00000147100 Solute carrier family 16, member 2 (thyroid hormone transporter) X 74421461-74533917 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072719 Approved Plasma membrane Mixed liver: 41.9 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Expressed in all skeletal muscle: 74.4 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced 0 kidney: 124.3 placenta: 39.9 SLC16A6 MCT6, MCT7 ENSG00000108932 Solute carrier family 16, member 6 17 68267026-68291267 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054459, HPA066328 Uncertain Approved Vesicles Tissue enhanced 0 epididymis: 39.8 esophagus: 12.1 SLC16A7 MCT2 ENSG00000118596 Solute carrier family 16 (monocarboxylate transporter), member 7 12 59596067-59789855 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005911 Approved Approved Nucleoplasm
Plasma membrane Mixed adipose tissue: 24.8 SLC16A8 MCT3, REMP ENSG00000100156 Solute carrier family 16 (monocarboxylate transporter), member 8 22 38078134-38084093 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA075017 Approved Intermediate filaments
Focal adhesion sites Mixed prostate: 5.7 SLC16A9 C10orf36, FLJ43803, MCT9 ENSG00000165449 Solute carrier family 16, member 9 10 59650761-59736002 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA049286 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 adrenal gland: 199.5;kidney: 199.2 spleen: 57.0 SLC17A1 NAPI-1, NPT1 ENSG00000124568 Solute carrier family 17 (organic anion transporter), member 1 6 25782897-25832059 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050513 Approved Golgi apparatus Tissue enriched 7 kidney: 173.1 liver: 25.2 SLC17A2 NPT3 ENSG00000112337 Solute carrier family 17, member 2 6 25912754-25930726 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038270 Uncertain Tissue enriched 85 liver: 40.9 testis: 0.4 SLC17A3 NPT4 ENSG00000124564 Solute carrier family 17 (organic anion transporter), member 3 6 25833066-25882286 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016569 Uncertain Tissue enriched 9 kidney: 167.2 liver: 18.5 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 SLC17A5 AST, ISSD, NSD, SD, SIALIN, SIASD, SLD ENSG00000119899 Solute carrier family 17 (acidic sugar transporter), member 5 6 73593379-73654155 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044479 Supported Plasma membrane
Cytosol Tissue enriched 9 parathyroid gland: 640.5 thyroid gland: 69.8 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037130, HPA039226 Supported Supported Tissue enriched 65 cerebral cortex: 6.5 epididymis: 0.0 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037183, HPA050458, HPA063679 Supported Tissue enriched 178 cerebral cortex: 586.2 adipose tissue: 3.2 SLC17A9 C20orf59, FLJ23412, VNUT ENSG00000101194 Solute carrier family 17 (vesicular nucleotide transporter), member 9 20 62952647-62969585 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA047470, HPA056499 Uncertain Approved Nucleoplasm Mixed stomach: 8.7 SLC18A1 CGAT, VAT1, VMAT1 ENSG00000036565 Solute carrier family 18 (vesicular monoamine transporter), member 1 8 20144855-20183206 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006877, HPA063797 Supported Tissue enriched 10 adrenal gland: 32.8 rectum: 3.1 SLC18A3 VACHT ENSG00000187714 Solute carrier family 18 (vesicular acetylcholine transporter), member 3 10 49610301-49612720 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB037102 Uncertain Not detected placenta: 0.6 SLC18B1 C6orf192, dJ55C23.6 ENSG00000146409 Solute carrier family 18, subfamily B, member 1 6 132769370-132798553 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029747, HPA049659 Approved Supported Golgi apparatus
Cytosol Expressed in all cerebral cortex: 37.6 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC19A2 THTR1, TRMA ENSG00000117479 Solute carrier family 19 (thiamine transporter), member 2 1 169463909-169486003 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006119, HPA016599 Uncertain Approved Cytosol Expressed in all gallbladder: 49.3 SLC19A3 THTR2 ENSG00000135917 Solute carrier family 19 (thiamine transporter), member 3 2 227685210-227718012 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038898 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 adipose tissue: 50.1;placenta: 34.5 duodenum: 12.7 SLC1A1 EAAC1, EAAT3 ENSG00000106688 Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 9 4490444-4587469 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015466, HPA020086 Approved Tissue enhanced 0 small intestine: 72.7 epididymis: 53.8 SLC1A2 EAAT2, GLT-1 ENSG00000110436 Solute carrier family 1 (glial high affinity glutamate transporter), member 2 11 35251206-35420063 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002574, HPA009172 Supported Tissue enriched 30 cerebral cortex: 367.1 liver: 12.2 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supported Approved Nucleoli
Mitochondria Tissue enriched 16 cerebral cortex: 519.6 adipose tissue: 31.7 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC20A1 Glvr-1, GLVR1, PiT-1 ENSG00000144136 Solute carrier family 20 (phosphate transporter), member 1 2 112645857-112663827 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019279, HPA035834 Approved Approved Vesicles Expressed in all colon: 51.9 SLC20A2 Glvr-2, GLVR2, MLVAR, PiT-2 ENSG00000168575 Solute carrier family 20 (phosphate transporter), member 2 8 42416475-42541926 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026540 Approved Expressed in all thyroid gland: 137.7 SLC22A1 OCT1 ENSG00000175003 Solute carrier family 22 (organic cation transporter), member 1 6 160121789-160158718 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029846 Approved Tissue enriched 252 liver: 286.8 gallbladder: 1.1 SLC22A11 OAT4 ENSG00000168065 Solute carrier family 22 (organic anion/urate transporter), member 11 11 64555626-64572875 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026076 Approved Group enriched 134 epididymis: 10.0;kidney: 25.9;placenta: 44.5 seminal vesicle: 0.2 SLC22A12 OAT4L, RST, URAT1 ENSG00000197891 Solute carrier family 22 (organic anion/urate transporter), member 12 11 64590641-64602353 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024575 Supported Tissue enriched 195 kidney: 104.6 adipose tissue: 0.5 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035603, HPA035962 Supported Tissue enriched 39 kidney: 10.6 testis: 0.2 SLC22A15 FLIPT1 ENSG00000163393 Solute carrier family 22, member 15 1 115976498-116070054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019785 Approved Approved Vesicles Tissue enhanced 0 bone marrow: 20.5 skin: 11.1 SLC22A16 CT2, FLIPT2, OAT6, OKB1 ENSG00000004809 Solute carrier family 22 (organic cation/carnitine transporter), member 16 6 110424687-110476641 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036902 Uncertain Group enriched 8 bone marrow: 13.0;parathyroid gland: 16.1;testis: 38.4 smooth muscle: 2.7 SLC22A17 BOCT, BOIT, NGALR ENSG00000092096 Solute carrier family 22, member 17 14 23346306-23352912 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002728 Uncertain Tissue enriched 6 cerebral cortex: 229.2 prostate: 38.6 SLC22A18 BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5 ENSG00000110628 Solute carrier family 22, member 18 11 2899721-2925246 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067812, HPA071461 Approved Tissue enhanced 0 duodenum: 44.5;small intestine: 32.4 colon: 10.5 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supported Tissue enriched 83 kidney: 149.2 seminal vesicle: 1.7 SLC22A23 C6orf85, FLJ22174 ENSG00000137266 Solute carrier family 22, member 23 6 3268962-3457022 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014697 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all stomach: 28.2 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045015 Uncertain Tissue enriched 46 kidney: 4.6 adipose tissue: 0.0 SLC22A25 HIMTP, MGC120420, UST6 ENSG00000196600 Solute carrier family 22, member 25 11 63163776-63229652 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039390 Uncertain Tissue enriched 57 liver: 5.7 epididymis: 0.0 SLC22A3 EMT, OCT3 ENSG00000146477 Solute carrier family 22 (organic cation transporter), member 3 6 160348268-160452581 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029750 Approved Approved Nucleoplasm
Vesicles
Cytosol Mixed seminal vesicle: 70.0 SLC22A4 MGC34546, OCTN1 ENSG00000197208 Solute carrier family 22 (organic cation/zwitterion transporter), member 4 5 132294443-132344206 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB015468, HPA036973 Approved Uncertain Nucleoplasm
Cytosol Tissue enhanced 0 fallopian tube: 18.6 bone marrow: 13.2 SLC22A5 CDSP, OCTN2, SCD ENSG00000197375 Solute carrier family 22 (organic cation/carnitine transporter), member 5 5 132369752-132395614 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063062 Approved Mitochondria Mixed parathyroid gland: 31.4 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supported Tissue enriched 391 kidney: 337.6 cerebral cortex: 0.8 SLC23A1 SLC23A2, SVCT1, YSPL3 ENSG00000170482 Solute carrier family 23 (ascorbic acid transporter), member 1 5 139367196-139384553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047612 Supported Group enriched 5 duodenum: 27.5;fallopian tube: 85.7;kidney: 41.7;small intestine: 73.4 liver: 10.7 SLC23A2 KIAA0238, SLC23A1, SVCT2, YSPL2 ENSG00000089057 Solute carrier family 23 (ascorbic acid transporter), member 2 20 4852356-5010293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052825, HPA059314 Approved Supported Golgi apparatus
Vesicles Expressed in all adrenal gland: 98.6 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA019059 Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC24A1 CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX ENSG00000074621 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15 65611366-65660995 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039370 Supported Approved Microtubules Mixed fallopian tube: 8.7 SLC24A3 ENSG00000185052 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 20 19212646-19722937 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043400, HPA045497 Uncertain Mixed endometrium: 47.4 SLC26A1 EDM4, SAT-1 ENSG00000145217 Solute carrier family 26 (anion exchanger), member 1 4 979073-993440 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041654 Uncertain Approved Microtubules Mixed kidney: 6.1 SLC26A10 ENSG00000135502 Solute carrier family 26, member 10 12 57619527-57626151 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044719 Uncertain Not detected endometrium: 0.5 SLC26A11 ENSG00000181045 Solute carrier family 26 (anion exchanger), member 11 17 80219699-80253500 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029893 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all adrenal gland: 34.5 SLC26A2 DTD, DTDST ENSG00000155850 Solute carrier family 26 (anion exchanger), member 2 5 149960737-149993455 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041957, HPA058090 Supported Approved Vesicles Tissue enhanced 0 colon: 215.9;rectum: 209.8 parathyroid gland: 81.4 SLC26A3 CLD, DRA ENSG00000091138 Solute carrier family 26 (anion exchanger), member 3 7 107765467-107803225 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036055 Approved Tissue enhanced 0 colon: 1092.5;duodenum: 594.0;rectum: 974.8 seminal vesicle: 183.9 SLC26A4 DFNB4, PDS ENSG00000091137 Solute carrier family 26 (anion exchanger), member 4 7 107660635-107717809 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042860 Approved Tissue enriched 28 thyroid gland: 422.9 cerebral cortex: 15.2 SLC26A6 DKFZp586E1422 ENSG00000225697 Solute carrier family 26 (anion exchanger), member 6 3 48625723-48635493 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048363 Approved Uncertain Cytosol Expressed in all rectum: 24.3 SLC26A8 ENSG00000112053 Solute carrier family 26 (anion exchanger), member 8 6 35943514-36024868 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038080, HPA038081 Uncertain Tissue enriched 27 testis: 75.6 bone marrow: 2.8 SLC26A9 ENSG00000174502 Solute carrier family 26 (anion exchanger), member 9 1 205913048-205943460 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051485 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 salivary gland: 31.7;stomach: 30.4 lung: 11.4 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 SLC28A2 CNT2, HCNT2, HsT17153, SPNT1 ENSG00000137860 Solute carrier family 28 (concentrative nucleoside transporter), member 2 15 45252230-45277845 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA046068, HPA055623 Supported Tissue enhanced 0 duodenum: 66.8;rectum: 37.9;small intestine: 100.1 stomach: 21.4 SLC28A3 CNT3 ENSG00000197506 Solute carrier family 28 (concentrative nucleoside transporter), member 3 9 84275457-84340683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA023311, HPA024729 Approved Tissue enhanced 0 breast: 10.7;gallbladder: 11.7;skin: 9.8 bone marrow: 6.2 SLC29A1 ENT1 ENSG00000112759 Solute carrier family 29 (equilibrative nucleoside transporter), member 1 6 44219505-44234151 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012384 Approved Expressed in all adrenal gland: 125.1 SLC29A2 DER12, ENT2, HNP36 ENSG00000174669 Solute carrier family 29 (equilibrative nucleoside transporter), member 2 11 66362521-66372214 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018168 Approved Uncertain Nucleoplasm Tissue enhanced 0 skeletal muscle: 36.4 parathyroid gland: 21.8 SLC29A3 ENT3, FLJ11160 ENSG00000198246 Solute carrier family 29 (equilibrative nucleoside transporter), member 3 10 71319258-71363385 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046085, HPA054976, HPA057905 Approved Supported Golgi apparatus
Vesicles Mixed placenta: 18.7 SLC29A4 ENT4, FLJ34923 ENSG00000164638 Solute carrier family 29 (equilibrative nucleoside transporter), member 4 7 5274369-5306870 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052829 Supported Microtubules
Cytokinetic bridge Tissue enhanced 0 adipose tissue: 44.2 cerebral cortex: 12.0 SLC2A1 CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR ENSG00000117394 Solute carrier family 2 (facilitated glucose transporter), member 1 1 42925375-42959173 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002759, HPA031345, HPA058494 Supported Supported Validated Plasma membrane Tissue enhanced 0 placenta: 133.9 skin: 31.3 SLC2A10 GLUT10 ENSG00000197496 Solute carrier family 2 (facilitated glucose transporter), member 10 20 46709487-46736347 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041015, HPA055673 Approved Supported Cytosol Mixed prostate: 46.7 SLC2A11 GLUT10, GLUT11 ENSG00000133460 Solute carrier family 2 (facilitated glucose transporter), member 11 22 23856703-23886309 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042960, HPA071184 Uncertain Uncertain Nucleus
Cell Junctions Mixed parathyroid gland: 10.7 SLC2A12 GLUT12, GLUT8 ENSG00000146411 Solute carrier family 2 (facilitated glucose transporter), member 12 6 133988697-134052636 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA031593, HPA031594 Approved Validated Plasma membrane
Cell Junctions Tissue enhanced 0 prostate: 38.8 endometrium: 15.7 SLC2A13 HMIT ENSG00000151229 Solute carrier family 2 (facilitated glucose transporter), member 13 12 39755021-40106089 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006584 Approved Approved Nuclear membrane Tissue enhanced 0 cerebral cortex: 49.5;parathyroid gland: 73.3 cervix: 20.3 SLC2A14 GLUT14, SLC2A3P3 ENSG00000173262 Solute carrier family 2 (facilitated glucose transporter), member 14 12 7812512-7891148 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006539 Approved Approved Plasma membrane Tissue enriched 9 testis: 151.1 breast: 17.2 SLC2A2 GLUT2 ENSG00000163581 Solute carrier family 2 (facilitated glucose transporter), member 2 3 170996348-171026750 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010444, HPA028997, HPA028998 Supported Approved Nucleoplasm Tissue enriched 6 liver: 432.5 duodenum: 67.5 SLC2A3 GLUT3 ENSG00000059804 Solute carrier family 2 (facilitated glucose transporter), member 3 12 7919230-7936275 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002763, HPA006539 Approved Approved Plasma membrane Tissue enhanced 0 bone marrow: 271.6 placenta: 137.6 SLC2A4 GLUT4 ENSG00000181856 Solute carrier family 2 (facilitated glucose transporter), member 4 17 7281667-7288257 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016544 Supported Tissue enhanced 0 heart muscle: 30.1;skeletal muscle: 45.0 adipose tissue: 21.9 SLC2A5 GLUT5 ENSG00000142583 Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 1 9035107-9088478 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005449 Supported Tissue enhanced 0 duodenum: 112.1;small intestine: 94.6;testis: 139.5 bone marrow: 64.6 SLC2A6 GLUT6, GLUT9, HSA011372 ENSG00000160326 Solute carrier family 2 (facilitated glucose transporter), member 6 9 133471095-133479137 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042272, CAB046014 Uncertain Mixed appendix: 6.3 SLC2A7 GLUT7 ENSG00000197241 Solute carrier family 2 (facilitated glucose transporter), member 7 1 9003300-9026345 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039931 Uncertain Group enriched 9 duodenum: 3.1;small intestine: 3.1 epididymis: 0.3 SLC2A8 GLUT8, GLUTX1 ENSG00000136856 Solute carrier family 2 (facilitated glucose transporter), member 8 9 127397138-127408424 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011935 Uncertain Approved Vesicles Expressed in all testis: 50.1 SLC2A9 Glut9, GLUTX, URATv1 ENSG00000109667 Solute carrier family 2 (facilitated glucose transporter), member 9 4 9771153-10054936 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066229 Approved Tissue enhanced 0 kidney: 30.9;seminal vesicle: 29.4 duodenum: 11.1 SLC30A5 FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1 ENSG00000145740 Solute carrier family 30 (zinc transporter), member 5 5 69093646-69131069 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035373 Approved Supported Nucleus
Golgi apparatus Expressed in all thyroid gland: 61.6 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037156, HPA058859, HPA059985 Supported Tissue enriched 34 cerebral cortex: 15.9 testis: 0.4 SLC33A1 ACATN, AT-1, AT1, SPG42 ENSG00000169359 Solute carrier family 33 (acetyl-CoA transporter), member 1 3 155821024-155854429 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042430 Uncertain Expressed in all thyroid gland: 67.1 SLC35B2 UGTrel4 ENSG00000157593 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 6 44254096-44257890 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029638 Approved Approved Vesicles Expressed in all parathyroid gland: 58.0 SLC35B3 C6orf196, CGI-19, dJ453H5.1, PAPST2 ENSG00000124786 Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 6 8413068-8435483 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054661, HPA057801 Approved Expressed in all epididymis: 62.2 SLC35C1 FLJ11320, FUCT1 ENSG00000181830 Solute carrier family 35 (GDP-fucose transporter), member C1 11 45804072-45813015 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064001 Supported Supported Golgi apparatus Expressed in all esophagus: 29.5 SLC35C2 bA394O2.1, C20orf5, CGI-15, OVCOV1 ENSG00000080189 Solute carrier family 35 (GDP-fucose transporter), member C2 20 46345980-46364458 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA027011 Approved Supported Nucleoplasm
Golgi apparatus Expressed in all fallopian tube: 36.6 SLC35D2 SQV7L, UGTrel8 ENSG00000130958 Solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 9 96320706-96383710 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA064047 Approved Validated Golgi apparatus Expressed in all small intestine: 73.8 SLC35D3 FRCL1 ENSG00000182747 Solute carrier family 35, member D3 6 136922264-136925639 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030431, HPA067497 Uncertain Approved Microtubule organizing center Tissue enhanced 0 adrenal gland: 1.2 lung: 0.6 SLC35E1 FLJ14251 ENSG00000127526 Solute carrier family 35, member E1 19 16549831-16572382 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016570, HPA062214 Approved Validated Golgi apparatus Expressed in all parathyroid gland: 29.2 SLC35E2B ENSG00000189339 Solute carrier family 35, member E2B 1 1659529-1692728 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045641, HPA062711 Uncertain Uncertain Nucleus Expressed in all smooth muscle: 47.0 SLC35E3 BLOV1 ENSG00000175782 Solute carrier family 35, member E3 12 68746106-68793964 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049403 Uncertain Mixed skin: 6.1 SLC35E4 ENSG00000100036 Solute carrier family 35, member E4 22 30635652-30669016 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049558 Approved Approved Cytosol Tissue enhanced 0 testis: 17.6 cerebral cortex: 5.1 SLC35F5 FLJ22004 ENSG00000115084 Solute carrier family 35, member F5 2 113705011-113756823 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034828, HPA049229 Uncertain Uncertain Plasma membrane Expressed in all thyroid gland: 65.7 SLC35G2 DKFZp564K2464, MGC3295, TMEM22 ENSG00000168917 Solute carrier family 35, member G2 3 136818647-136855892 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052054, HPA064728 Approved Approved Cytosol Mixed testis: 21.2 SLC36A1 LYAAT-1, PAT1, TRAMD3 ENSG00000123643 Solute carrier family 36 (proton/amino acid symporter), member 1 5 151437046-151492381 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035937 Approved Tissue enhanced 0 parathyroid gland: 64.1 duodenum: 45.5 SLC36A2 PAT2, TRAMD1, tramdorin ENSG00000186335 Solute carrier family 36 (proton/amino acid symporter), member 2 5 151314978-151347590 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044002, HPA062229 Supported Group enriched 26 kidney: 67.2;skeletal muscle: 28.1 testis: 1.8 SLC36A4 FLJ38932, PAT4 ENSG00000180773 Solute carrier family 36 (proton/amino acid symporter), member 4 11 93144171-93197964 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017887 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Mixed thyroid gland: 14.7 SLC37A1 ENSG00000160190 Solute carrier family 37 (glucose-6-phosphate transporter), member 1 21 42496008-42581440 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030418, CAB034154 Approved Approved Nucleus Mixed duodenum: 46.9 SLC37A2 FLJ00171 ENSG00000134955 Solute carrier family 37 (glucose-6-phosphate transporter), member 2 11 125063067-125090312 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014948 Uncertain Mixed adrenal gland: 24.8 SLC37A3 DKFZp761N0624 ENSG00000157800 Solute carrier family 37, member 3 7 140293693-140404433 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA014713, HPA061841 Supported Cytosol Expressed in all endometrium: 72.5 SLC37A4 G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d ENSG00000137700 Solute carrier family 37 (glucose-6-phosphate transporter), member 4 11 119024114-119030906 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038939, HPA038940 Approved Approved Mitochondria Tissue enhanced 0 duodenum: 31.4;kidney: 36.1 epididymis: 20.7 SLC38A1 ATA1, NAT2, SAT1 ENSG00000111371 Solute carrier family 38, member 1 12 46183063-46270017 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039460, HPA052272 Uncertain Supported Expressed in all parathyroid gland: 153.2 SLC38A10 MGC15523, PP1744 ENSG00000157637 Solute carrier family 38, member 10 17 81245000-81295547 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021374, HPA023161, HPA024631 Supported Validated Golgi apparatus Expressed in all thyroid gland: 44.6 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043432 Uncertain Tissue enhanced 0 epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SLC38A2 ATA2, KIAA1382, SAT2, SNAT2 ENSG00000134294 Solute carrier family 38, member 2 12 46358189-46372867 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035180 Approved Approved Vesicles Expressed in all skin: 239.3 SLC38A3 G17, SN1 ENSG00000188338 Solute carrier family 38, member 3 3 50205246-50221486 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031871 Approved Microtubules
Cytosol Tissue enriched 7 liver: 173.5 cerebral cortex: 25.6 SLC38A5 JM24, SN2 ENSG00000017483 Solute carrier family 38, member 5 X 48458537-48470256 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047411 Approved Approved Vesicles
Plasma membrane
Cytosol Mixed pancreas: 50.0 SLC38A6 NAT-1 ENSG00000139974 Solute carrier family 38, member 6 14 60981114-61083733 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018508 Approved Approved Plasma membrane
Cell Junctions
Microtubules Mixed parathyroid gland: 24.3 SLC38A7 FLJ10815 ENSG00000103042 Solute carrier family 38, member 7 16 58665109-58685104 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041777 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Mixed testis: 34.8 SLC38A9 FLJ90709 ENSG00000177058 Solute carrier family 38, member 9 5 55625845-55773194 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043785 Uncertain Approved Nucleoplasm
Vesicles Expressed in all placenta: 79.8 SLC40A1 FPN1, HFE4, IREG1, MTP1, SLC11A3 ENSG00000138449 Solute carrier family 40 (iron-regulated transporter), member 1 2 189560579-189583758 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065634 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all spleen: 496.0 SLC41A2 DKFZP434K0427 ENSG00000136052 Solute carrier family 41 (magnesium transporter), member 2 12 104802553-104958744 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038658 Approved Mixed liver: 59.8 SLC41A3 FLJ20473 ENSG00000114544 Solute carrier family 41, member 3 3 126006355-126101561 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045847 Approved Supported Plasma membrane Expressed in all testis: 79.0 SLC43A1 PB39, POV1, R00504 ENSG00000149150 Solute carrier family 43 (amino acid system L transporter), member 1 11 57484534-57515786 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018813, HPA018826 Supported Approved Golgi apparatus
Vesicles
Plasma membrane Expressed in all liver: 50.0 SLC43A2 MGC34680 ENSG00000167703 Solute carrier family 43 (amino acid system L transporter), member 2 17 1569267-1628886 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021564 Approved Tissue enhanced 0 placenta: 31.6 appendix: 17.4 SLC43A3 DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1 ENSG00000134802 Solute carrier family 43, member 3 11 57406954-57427580 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030551 Approved Expressed in all thyroid gland: 121.6 SLC44A1 CD92, CDW92, CHTL1, CTL1 ENSG00000070214 Solute carrier family 44 (choline transporter), member 1 9 105244622-105439171 CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064714 Supported Nucleoplasm
Mitochondria Expressed in all cerebral cortex: 107.8 SLC44A2 CTL2 ENSG00000129353 Solute carrier family 44 (choline transporter), member 2 19 10602457-10644559 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003228, HPA070799 Approved Approved Vesicles
Cell Junctions Expressed in all placenta: 224.3 SLC44A3 CTL3, MGC45474 ENSG00000143036 Solute carrier family 44, member 3 1 94820342-94895246 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047433 Approved Mixed rectum: 39.1 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Approved Tissue enhanced 0 duodenum: 36.0 prostate: 30.1 SLC44A5 CTL5, MGC34032 ENSG00000137968 Solute carrier family 44, member 5 1 75202131-75611116 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA047455, HPA051011 Uncertain Approved Cytosol Tissue enhanced 0 skin: 12.6 testis: 8.0 SLC45A3 IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein ENSG00000158715 Solute carrier family 45, member 3 1 205657851-205680459 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019073, HPA019075 Supported Approved Nucleoplasm
Vesicles Tissue enriched 25 prostate: 430.6 stomach: 16.9 SLC45A4 KIAA1126 ENSG00000022567 Solute carrier family 45, member 4 8 141207166-141308305 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023154 Uncertain Approved Plasma membrane Mixed testis: 21.1 SLC46A1 HCP1, MGC9564, PCFT ENSG00000076351 Solute carrier family 46 (folate transporter), member 1 17 28394756-28407197 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011614 Approved Supported Plasma membrane
Cytosol Expressed in all duodenum: 97.7 SLC46A2 Ly110, TSCOT ENSG00000119457 Solute carrier family 46, member 2 9 112878920-112890913 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020098 Approved Group enriched 6 cervix, uterine: 23.0;endometrium: 5.5;epididymis: 5.4;lung: 15.2;skin: 11.3 seminal vesicle: 2.0 SLC46A3 DKFZp686A1775, FLJ42613 ENSG00000139508 Solute carrier family 46, member 3 13 28700064-28718970 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039930 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Expressed in all small intestine: 89.4 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC4A1 AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR ENSG00000004939 Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) 17 44248385-44268141 Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015584, CAB034438, HPA063911 Supported Tissue enriched 8 bone marrow: 238.4 kidney: 29.9 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034755 Supported Tissue enriched 22 cerebral cortex: 57.7 adrenal gland: 2.6 SLC4A11 BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1 ENSG00000088836 Solute carrier family 4, sodium borate transporter, member 11 20 3227417-3239190 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018120, HPA058377 Uncertain Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 salivary gland: 19.3;thyroid gland: 27.6 cervix: 14.3 SLC4A2 AE2, BND3L, EPB3L1, HKB3, NBND3 ENSG00000164889 Solute carrier family 4 (anion exchanger), member 2 7 151057210-151076527 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019339 Supported Approved Nuclear speckles
Plasma membrane
Cytosol Expressed in all parathyroid gland: 87.8 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063498 Approved Nucleoplasm Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supported Tissue enhanced 0 kidney: 124.6 cerebral cortex: 57.5 SLC4A5 NBC4 ENSG00000188687 Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2 74216242-74343414 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036621 Approved Group enriched 9 testis: 25.5;thyroid gland: 40.5 skin: 3.7 SLC4A7 NBC3, SBC2, SLC4A6 ENSG00000033867 Solute carrier family 4, sodium bicarbonate cotransporter, member 7 3 27372721-27484420 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022494, HPA035857 Supported Supported Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 59.2 breast: 23.6 SLC4A8 NBC3 ENSG00000050438 Solute carrier family 4, sodium bicarbonate cotransporter, member 8 12 51391317-51515763 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031536 Uncertain Actin filaments Tissue enhanced 0 cerebral cortex: 14.6;testis: 15.4 ovary: 4.2 SLC4A9 AE4 ENSG00000113073 Solute carrier family 4, sodium bicarbonate cotransporter, member 9 5 140360202-140375143 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051307 Uncertain Tissue enriched 17 kidney: 12.1 testis: 0.6 SLC52A1 FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1 ENSG00000132517 Solute carrier family 52 (riboflavin transporter), member 1 17 5032600-5052009 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011449 Uncertain Group enriched 10 duodenum: 37.1;placenta: 26.0;skin: 13.3;small intestine: 26.8 parathyroid gland: 2.6 SLC52A2 D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2 ENSG00000185803 Solute carrier family 52 (riboflavin transporter), member 2 8 144354135-144361272 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063036 Approved Expressed in all placenta: 24.0 SLC52A3 bA371L19.1, C20orf54, hRFT2, RFVT3 ENSG00000101276 Solute carrier family 52 (riboflavin transporter), member 3 20 760080-776015 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049391 Approved Tissue enhanced 0 testis: 62.2 small intestine: 18.5 SLC5A1 D22S675, NAGT, SGLT1 ENSG00000100170 Solute carrier family 5 (sodium/glucose cotransporter), member 1 22 32043032-32113029 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015467, HPA051805, HPA055106 Supported Approved Nucleoplasm
Vesicles Group enriched 10 duodenum: 518.9;small intestine: 320.2 gallbladder: 40.3 SLC5A10 SGLT5 ENSG00000154025 Solute carrier family 5 (sodium/sugar cotransporter), member 10 17 18950345-19022595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052014 Uncertain Tissue enriched 25 kidney: 43.7 bone marrow: 1.7 SLC5A11 KST1, SGLT6, SMIT2 ENSG00000158865 Solute carrier family 5 (sodium/inositol cotransporter), member 11 16 24845841-24911628 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035331 Uncertain Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 10.5;duodenum: 6.8;kidney: 6.0;small intestine: 15.5 breast: 1.7 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supported Tissue enhanced 0 epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supported Tissue enriched 9 kidney: 25.3 testis: 2.8 SLC5A3 SMIT, SMIT1 ENSG00000198743 Solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 21 34073570-34106260 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA029791 Approved Plasma membrane
Cytosol Tissue enhanced 0 thyroid gland: 42.0 kidney: 32.9 SLC5A5 NIS ENSG00000105641 Solute carrier family 5 (sodium/iodide cotransporter), member 5 19 17871973-17895174 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB022364, HPA049055 Supported Tissue enhanced 0 salivary gland: 28.5;stomach: 56.7;thyroid gland: 20.6 cervix: 8.3 SLC5A6 SMVT ENSG00000138074 Solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 2 27199587-27212958 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036958 Approved Approved Cell Junctions Expressed in all epididymis: 82.1 SLC5A7 CHT1, hCHT ENSG00000115665 Solute carrier family 5 (sodium/choline cotransporter), member 7 2 107986523-108013994 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046105 Approved Nuclear bodies
Cell Junctions
Intermediate filaments Mixed thyroid gland: 2.0 SLC5A9 SGLT4 ENSG00000117834 Solute carrier family 5 (sodium/sugar cotransporter), member 9 1 48222685-48248644 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050263 Approved Actin filaments
Cytosol Group enriched 10 duodenum: 43.8;small intestine: 46.4 lung: 4.5 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037981 Supported Supported Tissue enhanced 0 cerebral cortex: 18.2;skin: 6.7 esophagus: 5.5 SLC6A12 BGT-1 ENSG00000111181 Solute carrier family 6 (neurotransmitter transporter), member 12 12 190077-214570 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034973, HPA057917 Approved Approved Golgi apparatus Tissue enhanced 0 kidney: 29.4;liver: 43.6 cerebral cortex: 14.8 SLC6A13 GAT2 ENSG00000010379 Solute carrier family 6 (neurotransmitter transporter), member 13 12 220621-262873 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036449, HPA052726 Approved Approved Mitochondria Tissue enriched 14 kidney: 152.9 fallopian tube: 11.2 SLC6A14 ENSG00000268104 Solute carrier family 6 (amino acid transporter), member 14 X 116436622-116461458 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003193 Uncertain Approved Vesicles Tissue enhanced 0 cervix, uterine: 11.0;lung: 23.9 breast: 9.2 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A16 NTT5 ENSG00000063127 Solute carrier family 6, member 16 19 49289638-49325225 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA076812 Approved Golgi apparatus Tissue enriched 18 testis: 161.8 lymph node: 9.0 SLC6A17 ENSG00000197106 Solute carrier family 6 (neutral amino acid transporter), member 17 1 110150486-110202202 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007663, HPA008044 Approved Approved Nucleus
Golgi apparatus Tissue enriched 10 cerebral cortex: 75.6 adrenal gland: 7.9 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA011885 Supported Tissue enriched 83 kidney: 8.2 epididymis: 0.0 SLC6A19 ENSG00000174358 Solute carrier family 6 (neutral amino acid transporter), member 19 5 1201595-1225117 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037415, HPA043207 Supported Group enriched 21 duodenum: 143.3;kidney: 91.3;small intestine: 160.0 rectum: 6.3 SLC6A2 NAT1, NET, NET1, SLC6A5 ENSG00000103546 Solute carrier family 6 (neurotransmitter transporter), member 2 16 55655604-55706192 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004057, CAB078195 Supported Supported Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 29.4;placenta: 18.2;skin: 15.7 testis: 11.4 SLC6A20 XT3, Xtrp3 ENSG00000163817 Solute carrier family 6 (proline IMINO transporter), member 20 3 45755450-45796535 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029873 Approved Tissue enhanced 0 duodenum: 25.1;small intestine: 19.7 gallbladder: 10.9 SLC6A3 DAT, DAT1 ENSG00000142319 Solute carrier family 6 (neurotransmitter transporter), member 3 5 1392790-1445430 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level HPA013602, CAB016249, CAB078172 Uncertain Supported Approved Vesicles Not detected thyroid gland: 0.3 SLC6A4 5-HTT, HTT, OCD1, SERT1 ENSG00000108576 Solute carrier family 6 (neurotransmitter transporter), member 4 17 30194319-30236002 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054723, HPA074728 Supported Supported Golgi apparatus
Vesicles Group enriched 10 duodenum: 10.7;lung: 44.2;placenta: 26.3;small intestine: 46.2 esophagus: 3.1 SLC6A6 TAUT ENSG00000131389 Solute carrier family 6 (neurotransmitter transporter), member 6 3 14402576-14489349 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015028, HPA016488 Supported Approved Cell Junctions
Cytosol Mixed ovary: 50.7 SLC6A7 PROT ENSG00000011083 Solute carrier family 6 (neurotransmitter transporter), member 7 5 150189957-150222788 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028907 Uncertain Tissue enhanced 0 cerebral cortex: 17.0;rectum: 4.3 colon: 2.9 SLC6A9 GLYT1 ENSG00000196517 Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1 43991500-44031467 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013977 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced 0 skin: 49.8 adrenal gland: 31.0 SLC7A1 ATRC1, CAT-1, ERR, HCAT1, REC1L ENSG00000139514 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 13 29509410-29595688 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039721 Approved Mixed esophagus: 42.0 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SLC7A11 xCT ENSG00000151012 Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 4 138164097-138242349 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064215 Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.5 epididymis: 8.2 SLC7A14 KIAA1613, PPP1R142 ENSG00000013293 Solute carrier family 7, member 14 3 170459584-170586074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045929 Approved Tissue enriched 8 cerebral cortex: 26.8 adrenal gland: 3.1 SLC7A2 ATRC2, CAT-2, HCAT2 ENSG00000003989 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 8 17497088-17570573 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009277 Supported Plasma membrane
Cell Junctions Tissue enhanced 0 parathyroid gland: 373.7 liver: 92.6 SLC7A3 ATRC3, CAT-3, FLJ14541 ENSG00000165349 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 X 70925582-70931125 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003629 Approved Tissue enhanced 0 endometrium: 7.8;prostate: 9.6;seminal vesicle: 7.4 smooth muscle: 4.0 SLC7A4 CAT-4, HCAT3, VH ENSG00000099960 Solute carrier family 7, member 4 22 21028718-21032840 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA031023 Approved Tissue enhanced 0 testis: 22.5 esophagus: 6.0 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Approved Supported Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 90.5;testis: 84.4 bone marrow: 66.3 SLC7A6 KIAA0245, LAT-2, LAT3, y+LAT-2 ENSG00000103064 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 16 68264516-68301823 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050713 Uncertain Approved Vesicles
Plasma membrane Mixed adipose tissue: 35.1 SLC7A7 LPI, y+LAT-1 ENSG00000155465 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14 22773222-22829820 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036227 Approved Tissue enhanced 0 kidney: 279.7 parathyroid gland: 159.0 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supported Tissue enriched 8 parathyroid gland: 1066.4 kidney: 131.5 SLC7A9 CSNU3 ENSG00000021488 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19 32830509-32869766 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042591 Supported Group enriched 10 duodenum: 81.2;kidney: 69.6;small intestine: 125.7 liver: 8.9 SLC8A1 NCX1 ENSG00000183023 Solute carrier family 8 (sodium/calcium exchanger), member 1 2 40097270-40611053 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022694, HPA070007 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 heart muscle: 79.5 seminal vesicle: 38.2 SLC8B1 FLJ22233, NCKX6, NCLX, SLC24A6 ENSG00000089060 Solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 12 113298759-113359493 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA040668 Approved Expressed in all adrenal gland: 48.6 SLC9A1 APNH, NHE1, PPP1R143 ENSG00000090020 Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 1 27098815-27166981 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022371, HPA048532, HPA052891 Supported Supported Plasma membrane Expressed in all stomach: 66.4 SLC9A2 NHE2 ENSG00000115616 Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 2 102619707-102711318 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA035121, HPA035122 Approved Approved Cell Junctions Tissue enhanced 0 colon: 20.9;rectum: 23.7;stomach: 25.8 testis: 10.6 SLC9A3 NHE3 ENSG00000066230 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 5 473310-524332 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036493, HPA036669 Supported Supported Plasma membrane Tissue enhanced 0 colon: 82.6;small intestine: 74.1 gallbladder: 66.3 SLC9A4 NHE4 ENSG00000180251 Solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 2 102473303-102533972 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036096 Approved Approved Nucleoplasm
Plasma membrane Tissue enriched 5 stomach: 51.1 kidney: 9.5 SLC9A5 NHE5 ENSG00000135740 Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 16 67237683-67272190 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041004, HPA041329 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 spleen: 7.8 cerebral cortex: 2.5 SLC9A6 KIAA0267, NHE6 ENSG00000198689 Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 X 135985424-136047269 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059445, HPA059590 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 76.1 parathyroid gland: 17.3 SLC9A7 NHE7 ENSG00000065923 Solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 X 46599252-46759172 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048938, HPA075385 Approved Supported Vesicles Mixed cerebral cortex: 14.4 SLC9A8 KIAA0939, NHE8 ENSG00000197818 Solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 20 49812713-49892242 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033682 Approved Expressed in all bone marrow: 13.2 SLC9A9 FLJ35613, NHE9 ENSG00000181804 Solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 3 143265222-143848531 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058234 Approved Mixed placenta: 22.1 SLC9B1 NHA1, NHEDC1 ENSG00000164037 Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 4 102885048-103019739 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035435, HPA058971, HPA065520 Uncertain Approved Mitochondria Tissue enriched 25 testis: 73.9 epididymis: 2.9 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SLCO1A2 OATP, OATP-A, OATP1A2, SLC21A3 ENSG00000084453 Solute carrier organic anion transporter family, member 1A2 12 21264600-21419594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA071152 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 28.8 salivary gland: 6.6 SLCO1B1 LST-1, OATP-C, OATP1B1, SLC21A6 ENSG00000134538 Solute carrier organic anion transporter family, member 1B1 12 21131202-21239246 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050892 Supported Tissue enriched 249 liver: 307.4 breast: 1.2 SLCO1B3 OATP1B3, OATP8, SLC21A8 ENSG00000111700 Solute carrier organic anion transporter family, member 1B3 12 20810702-20916911 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004943, HPA050892 Supported Supported Plasma membrane Tissue enriched 7 liver: 138.5 cervix: 19.4 SLCO1B7 LST3, SLC21A21 ENSG00000205754 Solute carrier organic anion transporter family, member 1B7 (non-functional) 12 21015696-21092745 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA050892 Uncertain Tissue enriched 21 breast: 42.5 liver: 2.0 SLCO2A1 MATR1, OATP2A1, PGT, SLC21A2 ENSG00000174640 Solute carrier organic anion transporter family, member 2A1 3 133932696-134052184 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013742 Supported Tissue enhanced 0 seminal vesicle: 113.4 thyroid gland: 71.0 SLCO2B1 OATP-B, OATP2B1, SLC21A9 ENSG00000137491 Solute carrier organic anion transporter family, member 2B1 11 75100563-75206549 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020659 Uncertain Expressed in all liver: 123.0 SLCO4A1 OATP-E, OATP4A1, SLC21A12 ENSG00000101187 Solute carrier organic anion transporter family, member 4A1 20 62642445-62685785 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030669, HPA030670 Uncertain Approved Cell Junctions Mixed esophagus: 10.6 SLCO5A1 OATP-J, OATP5A1, OATPRP4, SLC21A15 ENSG00000137571 Solute carrier organic anion transporter family, member 5A1 8 69667047-69835064 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA025062 Uncertain Tissue enhanced 0 prostate: 3.6 skeletal muscle: 2.6 SLCO6A1 CT48, MGC26949, OATP6A1, OATPY ENSG00000205359 Solute carrier organic anion transporter family, member 6A1 5 102371782-102499016 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA054126 Supported Tissue enriched 136 testis: 53.7 placenta: 0.3 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supported Approved Nucleoli fibrillar center
Golgi apparatus
Vesicles
Cytosol Expressed in all parathyroid gland: 36.3 SPNS2 ENSG00000183018 Spinster homolog 2 (Drosophila) 17 4498838-4539035 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA068717 Uncertain Tissue enhanced 0 esophagus: 46.5 kidney: 29.9 SPNS3 MGC29671 ENSG00000182557 Spinster homolog 3 (Drosophila) 17 4433688-4488208 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023928 Uncertain Tissue enriched 6 bone marrow: 12.4 spleen: 2.1 STRA6 FLJ12541 ENSG00000137868 Stimulated by retinoic acid 6 15 74179466-74212267 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040839 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cervix, uterine: 37.3;placenta: 20.4 endometrium: 13.5 STT3A ITM1, MGC9042, STT3-A, TMC ENSG00000134910 STT3A, subunit of the oligosaccharyltransferase complex (catalytic) 11 125591712-125625215 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030735 Approved Uncertain Nucleoplasm
Vesicles
Cytosol Tissue enriched 6 parathyroid gland: 1111.5 epididymis: 173.1 STT3B FLJ90106, SIMP, STT3-B ENSG00000163527 STT3B, subunit of the oligosaccharyltransferase complex (catalytic) 3 31532638-31637622 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036448, HPA036646 Approved Supported Endoplasmic reticulum Expressed in all testis: 164.6 SV2A KIAA0736, SV2 ENSG00000159164 Synaptic vesicle glycoprotein 2A 1 149903318-149917882 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002226, HPA007863 Supported Approved Cytosol Tissue enhanced 0 cerebral cortex: 167.4;parathyroid gland: 70.8 epididymis: 27.9 SV2B HsT19680, KIAA0735 ENSG00000185518 Synaptic vesicle glycoprotein 2B 15 91099950-91301309 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046247 Approved Tissue enriched 23 cerebral cortex: 48.1 adipose tissue: 2.1 SV2C ENSG00000122012 Synaptic vesicle glycoprotein 2C 5 76083172-76353939 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA040722, HPA040770 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 1.7;cerebral cortex: 3.4 ovary: 0.6 SVOP DKFZp761H039 ENSG00000166111 SV2 related protein 12 108907741-109021240 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA016573 Uncertain Tissue enriched 15 cerebral cortex: 32.4 adrenal gland: 2.1 SVOPL MGC46715 ENSG00000157703 SVOP-like 7 138594285-138701352 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018035 Uncertain Tissue enriched 5 parathyroid gland: 14.0 fallopian tube: 2.6 TMC7 FLJ21240 ENSG00000170537 Transmembrane channel-like 7 16 18983934-19063942 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029465 Uncertain Approved Vesicles Tissue enhanced 0 testis: 17.7 cerebral cortex: 10.7 TMCO3 C13orf11, FLJ20623 ENSG00000150403 Transmembrane and coiled-coil domains 3 13 113490995-113554590 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039561, HPA048126 Uncertain Approved Cytosol Expressed in all cervix: 49.2 TMEM104 FLJ00021, FLJ20255 ENSG00000109066 Transmembrane protein 104 17 74776483-74839779 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044330 Approved Approved Nucleoplasm
Golgi apparatus Expressed in all parathyroid gland: 14.7 TMEM168 DKFZp564C012, FLJ13576 ENSG00000146802 Transmembrane protein 168 7 112762382-112790592 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA020389 Approved Expressed in all parathyroid gland: 43.5 TMEM175 MGC4618 ENSG00000127419 Transmembrane protein 175 4 932387-958656 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057160 Approved Approved Nucleus
Nuclear membrane Expressed in all cerebral cortex: 20.8 TMEM245 C9orf5, CG-2 ENSG00000106771 Transmembrane protein 245 9 109015152-109119945 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023892 Approved Approved Plasma membrane
Cytosol Expressed in all thyroid gland: 123.5 TMEM63A KIAA0792 ENSG00000196187 Transmembrane protein 63A 1 225845536-225882369 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066504, HPA066936, HPA068918 Validated Vesicles
Microtubule organizing center Expressed in all cerebral cortex: 77.4 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Uncertain Validated Plasma membrane
Actin filaments Expressed in all lung: 59.2 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030657 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TMEM94 KIAA0195 ENSG00000177728 Transmembrane protein 94 17 75441159-75500090 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008423, HPA050660 Approved Supported Nucleoplasm
Nuclear bodies Expressed in all cerebral cortex: 54.3 TMTC1 ARG99, FLJ31400, FLJ41625, OLF ENSG00000133687 Transmembrane and tetratricopeptide repeat containing 1 12 29500840-29784759 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA016720 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 spleen: 61.6 adipose tissue: 41.5 TMTC2 DKFZp762A217 ENSG00000179104 Transmembrane and tetratricopeptide repeat containing 2 12 82686880-83134870 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA026954, HPA026955 Uncertain Approved Actin filaments
Cytosol Mixed cerebral cortex: 16.4 TMTC3 FLJ90492, SMILE ENSG00000139324 Transmembrane and tetratricopeptide repeat containing 3 12 88142296-88199887 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038550 Approved Approved Microtubules Mixed skin: 14.9 TMTC4 FLJ14624, FLJ22153 ENSG00000125247 Transmembrane and tetratricopeptide repeat containing 4 13 100603927-100675093 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA016489 Uncertain Approved Vesicles Expressed in all cerebral cortex: 26.5 TPCN1 FLJ20612, KIAA1169, TPC1 ENSG00000186815 Two pore segment channel 1 12 113221050-113298585 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039757 Approved Expressed in all thyroid gland: 53.3 TPCN2 TPC2 ENSG00000162341 Two pore segment channel 2 11 69048897-69090604 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016561, HPA027080 Supported Approved Nucleoli Mixed endometrium: 11.7 UNC93A dJ366N23.1, dJ366N23.2 ENSG00000112494 Unc-93 homolog A (C. elegans) 6 167271169-167316019 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA035729 Uncertain Tissue enhanced 0 duodenum: 9.9;skin: 17.9 liver: 7.1 UNC93B1 UNC93 ENSG00000110057 Unc-93 homolog B1 (C. elegans) 11 67991104-68004982 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038716, HPA038717, HPA042803 Approved Approved Nucleoplasm Mixed spleen: 56.6